ABOUT ABBV-744 IN CLINICAL TRIALS FOR NON-SMALL CELL LUNG CANCER (NSCLC)

In Segment A, contributors will receive various doses and schedules of oral ABBV-744 pill to establish Safe and sound dosing routine. Extra participants will be enrolled for the recognized monotherapy dosign regimen. In Section B, participants will get oral ruxolitinib and ABBV-744 is going to be presented as "include-on" therapy. In Phase C, indiv